Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Immunogenicity and Booster Kinetics of Encepur in Adults
NCT00311493Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2006
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Novartis. Primary endpoint: Long-term antibody kinetics as measured by ELISA and neutralisation test (NT). Started Feb 2006; status: completed.
02
Drugs
tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00311493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311493.